NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Adriamycin


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from University zu Koln in neutropenia therapy reported
2009 NOV 1 ... categories docetaxel-doxorubicin (45.4%) and cyclophosphamide-hydroxy daunomycin (adriamycin)-oncovin (vincristine)-prednisolone (CHOP)/platinum(Pt)-vinorelbine or Pt-vinblastine/ ...
Subject: Neutropenia Therapy
Price: $3.00
*
Investigators at University of the West Indies publish new data on cervical lymphadenopathy
2009 SEP 28 ... He received local irradiation and 6 courses of chemotherapy comprising vincristine, adriamycin, and dexamethasone given at 4 weekly intervals," wrote D.C. Bradywest and colleagues, ...
Subject: Cervical Lymphadenopathy
Price: $3.00
*
New nephrology data have been reported by researchers at Vanderbilt University
2009 NOV 9 ... (COX-2) selectively in podocytes are more susceptible to glomerular injury by adriamycin and puromycin (PAN). To investigate the potential roles of COX-2 metabolites, we studied ...
Subject: Nephrology
Price: $3.00
*
New pancreatic cancer research from J. Yoshizawa and co-researchers described
2009 OCT 5 ... line MIA PaCa-2: gemcitabine (GEM), cisplatin (CDDP), irinotecan (CPT-11), mitomycin C, adriamycin, and paclitaxel." "The efficacy of S-1, GEM, and a combination of S-1 and ...
Subject: Pancreatic Cancer
Price: $3.00
*
Reports from H. Blasco and co-researchers add new data to research in non-hodgkin lymphoma
2009 NOV 2 ... four courses of rituximab (375 mg/m(2)) associated with CHOP (cyclophosphamide, adriamycin, vincristine and prednisone) at 21-day intervals. Blood samples were collected from each ...
Subject: Non-Hodgkin Lymphoma
Price: $3.00
*
Research from Dong-A University, Medical Department reveals new findings on cancer
2009 SEP 21 ... 530 Walnut St., Philadelphia, PA 19106-3621, USA. Keywords: South Korea, Adriamycin, Antimetabolite, Antineoplastic, Antiviral, Chemotherapy, Clinical Oncology, Clinical ...
Subject: Cancer
Price: $3.00
*
Research from Fudan University provides new data on angiogenesis
2009 SEP 28 ... cells, response to tumor conditioned medium, and reactions to the chemotherapy drugs Adriamycin and 5-fluorouracil and the antiangiogenic drug sorafenib. Compared with CD105(+) NECs ...
Subject: Angiogenesis
Price: $3.00
*
Research from University of Pittsburgh, Medical Department has provided new information about proteinuria
2009 NOV 9 ... the Journal of the American Society of Nephrology report. "Treatment with adriamycin induced Wnt and activated beta-catenin in mouse podocytes. Overexpression of Wnt1 in ...
Subject: Proteinuria
Price: $3.00
*
Researchers at Brigham and Women's Hospital release new data on lymphoma prognosis
2009 NOV 16 ... with consolidative involved-field radiotherapy (IFRT). Patients with HL treated with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)-based CT and radiotherapy (RT) at our ...
Subject: Lymphoma Prognosis
Price: $3.00
*
Researchers at University of Milan target ovarian cancer
2009 OCT 5 ... January 1995, and December 2006, and treated with a combination regimen of cisplatin, adriamycin, and cyclophosphamide or a combination regimen containing of cisplatin, epirubicin, and ...
Subject: Ovarian Cancer
Price: $3.00
*
Researchers from University of California publish new studies and findings in the area of cardiomyopathy
2009 NOV 9 ... and is a novel target of the antineoplastic and cardiomyopathic drug doxorubicin (Dox(adriamycin)). Hearts of rats that develop cardiomyopathy following chronic treatment with Dox also ...
Subject: Cardiomyopathy
Price: $3.00
*
Researchers from University of Texas report details of new studies and findings in the area of chronic myeloid leukemia
2009 OCT 19 ... CHR. BP patients received hyper-CVAD (hyperfractionated cyclophosphamide, vincristine, adriamycin, dexamethasone) plus imatinib/dasatinib or idarubicin plus cytarabine (Ara-C); 2 did not ...
Subject: Chronic Myeloid Leukemia
Price: $3.00
*
Scientists at Gifu University, Medical Department detail research in B-cell lymphoma
2009 OCT 19 ... B: with rituximab). The patients received eight cycles of CHOP or THP (tetrahydropyranyl-adriamycin)-COP before September 2002, and R-CHOP or R-THP-COP after October 2002. The distribution ...
Subject: B-Cell Lymphoma
Price: $3.00
*
Scientists at University of Tokyo detail research in analytical science
2009 NOV 23 ... concluded: "Organ-specific toxicity of aflatoxin B-1 and non-specific toxicity of adriamycin were successfully detected by using the cell array chip."Komori and ...
Subject: Analytical Science
Price: $3.00
*
Studies by D. Ternant and co-authors describe new findings in lymphoma therapy
2009 NOV 9 ... rituximab combined with chemotherapy [rituximab, cyclophosphamide, vincristine, adriamycin and prednisone (R-CHOP)] in 334 relapsed/resistant FL patients and a study that ...
Subject: Lymphoma Therapy
Price: $3.00
*
Studies from University of Strasbourg further understanding of apoptosis
2009 OCT 19 ... 3 enhanced doxorubicin cytotoxicity in HepG2 cells and retained its potency against. adriamycin-resistant cell lines without inducing cardiomyocyte toxicity. Compound 3 induced ...
Subject: Apoptosis
Price: $3.00
*
Study data from Sichuan University provide new insights into breast cancer
2009 NOV 23 ... the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and adriamycin (ADM) on the human breast cancer cell line MCF-7 and to identify potential mechanisms of ...
Subject: Breast Cancer
Price: $3.00
*
University of Heidelberg describes research in breast cancer therapy
2009 NOV 16 ... continuous infusion on days 1-7 in combination with standard-dose docetaxel (Taxotere), Adriamycin and cyclophosphamide (TAC) on day 5 as preoperative chemotherapy in 28 patients with ...
Subject: Breast Cancer Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login